Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings

Shares (Q2 2026)
35,018
Value
$4.29M
% of portfolio
2.0%
Quarters held
22
Since Q1 2021
Holdings of PTGX by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202635,018$4.29M2.0%+18+0.1%AddedHolders
Q1 202635,000$3.69M2.1%−20,000−36.4%ReducedHolders
Q4 202555,000$4.80M2.8%+7,000+14.6%AddedHolders
Q3 202548,000$3.19M2.4%00.0%UnchangedHolders
Q2 202548,000$2.65M2.6%−20.0%ReducedHolders
Q1 202548,002$2.32M2.0%+20.0%AddedHolders
Q4 202448,000$1.85M1.5%00.0%UnchangedHolders
Q3 202448,000$2.16M1.9%00.0%UnchangedHolders
Q2 202448,000$1.66M1.5%00.0%UnchangedHolders
Q1 202448,000$1.39M1.1%00.0%UnchangedHolders
Q4 202348,000$1.10M0.9%+10,000+26.3%AddedHolders
Q3 202338,000$633.8K0.5%00.0%UnchangedHolders
Q2 202338,000$1.05M0.8%00.0%UnchangedHolders
Q1 202338,000$874.0K0.7%00.0%UnchangedHolders
Q4 202238,000$415.0K0.3%00.0%UnchangedHolders
Q3 202238,000$320.0K0.2%00.0%UnchangedHolders
Q2 202238,000$301.0K0.2%00.0%UnchangedHolders
Q1 202238,000$900.0K0.6%00.0%UnchangedHolders
Q4 202138,000$1.30M0.8%00.0%UnchangedHolders
Q3 202138,000$673.0K0.5%+28,000+280.0%AddedHolders
Q2 202110,000$449.0K0.3%00.0%UnchangedHolders
Q1 202110,000$259.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.